Publicaciones en colaboración con investigadores/as de Queen's University Belfast (23)

2022

  1. Corrigendum to “Obesity II: Establishing causal links between chemical exposures and obesity” [Biochem. Pharmacol. 199 (2022) 115015] (Biochemical Pharmacology (2022) 199, (S0006295222001095), (10.1016/j.bcp.2022.115015))

    Biochemical Pharmacology

  2. Erratum: Meeting report: Plant-rich dietary patterns and health (Proceedings of the Nutrition Society (2022) (1-8)DOI: 10.1017/S002966512200266X)

    Proceedings of the Nutrition Society

  3. Obesity II: Establishing causal links between chemical exposures and obesity

    Biochemical Pharmacology, Vol. 199

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Association of ABCB1 and VEGFA gene polymorphisms with breast cancer susceptibility and prognosis

    Pathology Research and Practice, Vol. 216, Núm. 4

  2. Effect of DPYD, MTHFR, ABCB1, XRCC1, ERCC1 and GSTP1 on chemotherapy related toxicity in colorectal carcinoma

    Surgical Oncology, Vol. 35, pp. 388-398

2019

  1. Impact of single nucleotide polymorphisms on the efficacy and toxicity of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer patients

    Mutation Research - Reviews in Mutation Research, Vol. 781, pp. 63-70

  2. Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients

    Pharmacogenomics Journal, Vol. 19, Núm. 2, pp. 164-177

2018

  1. Analysis of shared heritability in common disorders of the brain

    Science, Vol. 360, Núm. 6395

  2. Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer

    Pathology Research and Practice, Vol. 214, Núm. 1, pp. 44-52

  3. Trends in incidence of thick, thin and in situ melanoma in Europe

    European Journal of Cancer, Vol. 92, pp. 108-118

2017

  1. Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413](S0090825816314974)(10.1016/j.ygyno.2016.10.019)

    Gynecologic Oncology

  2. Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404](S009082581631575X)(10.1016/j.ygyno.2016.11.019)

    Gynecologic Oncology

  3. Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer

    Surgical Oncology, Vol. 26, Núm. 3, pp. 278-285

2016

  1. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

    Science Translational Medicine, Vol. 8, Núm. 341

2015

  1. Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

    The Lancet, Vol. 385, Núm. 9972, pp. 977-1010

  2. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: Meta-analysis of Individual participant data from prospective cohort studies of the CHANCES consortium

    The BMJ, Vol. 350

  3. Smoking and All-cause Mortality in Older Adults: Results From the CHANCES Consortium

    American Journal of Preventive Medicine, Vol. 49, Núm. 5, pp. e53-e63

2013

  1. Mapping stone surface temperature fluctuations: Implications for lichen distribution and biomodification on historic stone surfaces

    Journal of Cultural Heritage, Vol. 14, Núm. 4, pp. 346-353

2012

  1. Oesophageal cancer survival in Europe: A EUROCARE-4 study

    Cancer Epidemiology, Vol. 36, Núm. 6, pp. 505-512